Latest Bispecific monoclonal antibody Stories
Conference call today at 4:30 p.m. EST MONROVIA, Calif., Nov. 10, 2014 /PRNewswire/ -- Xencor Inc.
Collaboration to Express Antibodies and Antigens based on Sutro's Technology Platform Xpress CF(TM) SAN FRANCISCO, Sept.
MUMBAI, August 20, 2014 /PRNewswire/ -- Glenmark Pharmaceuticals S.A.
SAN DIEGO, July 1, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
MUMBAI and LA CHAUX-DE-FONDS, Switzerland, June 4, 2014 /PRNewswire/ -- - State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material -
MONROVIA, Calif., March 28, 2014 /PRNewswire/ -- Xencor, Inc.
SAN FRANCISCO, March 24, 2014 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates
DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/885sfr/bispecific ) has announced the addition of the "Concise Analysis
SAN FRANCISCO, Jan.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.